Pharming Group NV (PHAR) Social Stream



Pharming Group NV (PHAR): $7.86

-0.90 (-10.27%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add PHAR to Watchlist
Sign Up

Industry: Biotech


Ranked

of 481

in industry

Pharming Group NV (PHAR) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering PHAR.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-16 2 $43 $43 $43 $8.491 406.42%
2022-02-03 2 $43 $37 $40 $8.491 371.09%

PHAR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, Pharming Group NV's number of analysts covering the stock is higher than 9.36% of them.
  • In terms of how Pharming Group NV fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 89.33% of that group.
  • Pharming Group NV's upside potential (average analyst target price relative to current price) is higher than 257.7% of stocks in the small market cap category.
  • In the context of stocks in the small market cap category, Pharming Group NV's average analyst price target is greater than 246.52% of them.

Stocks similar to Pharming Group NV in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PDSB, OVID, and OTIC.

Is PHAR a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4279 seconds.